Callan Capital’s BIOMED REALTY TRUST INC BMR Stock Holding History

Callan Capital’s Portfolio BMR Stock Details BMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-64,584	Closed	-$1.53M	–	66
2015 Q4	$1.53M	Hold	64,584	–	–	0.61%	24
2015 Q3	$1.29M	Hold	64,584	–	–	0.7%	26
2015 Q2	$1.25M	Hold	64,584	–	–	0.26%	39
2015 Q1	$1.46M	Buy	64,584 +4,415	+7%	+$101K	0.31%	35
2014 Q4	$1.3M	Hold	60,169	–	–	0.29%	42
2014 Q3	$1.22M	Buy	+60,169	New	+$1.31M	0.34%	39

Other funds holding BMR

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

MAM

Mizuho Asset Management Tokyo, Japan $462M AUM 15.39% 1-Year Est. Return

Kimelman & Baird New York $1.22B AUM 11.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Callan Capital's BMR Position: Q1 2016 in Review

Callan Capital sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 64,584 shares — an estimated $1.53M sold.

Callan Capital first reported a position in BMR in Q3 2014 and held it in 6 quarters. The position peaked at $1.53M in Q4 2015. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

Callan Capital reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
Callan Capital sold 64,584 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $1.53M.
Callan Capital first reported a position in BIOMED REALTY TRUST INC in Q3 2014 and held it in 6 quarters.
Callan Capital's BIOMED REALTY TRUST INC position peaked at $1.53M in Q4 2015.
4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on Callan Capital's 13F filing for Q1 2016, filed 11 May 2016.